FDA Approves Implant For Enlarged Prostate

WASHINGTON (September 13, 2013)—The U.S. Food and Drug Administration has approved the Urolift system to relieve low or blocked urine flow in men age 50 or older.

The implant works by holding back prostate tissue that presses against the urethra, causing difficulty urinating.

More than half of men in their sixties have some urinary problems resulting from an enlarged prostate, including frequent urination, weak stream and leakage.

Current treatment options include drug therapy and surgery to remove part of the prostate.

The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.

Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.

KWTX-TV News 10 6700 American Plaza Waco, Texas 76712 (254) 776-1330 Fax (254) 751-1088
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 223664651 - kwtx.com/a?a=223664651
Gray Television, Inc.